Posts tagged as

Parkinson’s Disease

Weight and survival after deep brain stimulation for Parkinson’s disease

Congratulations Drs. Okun, Foote, Ramirez-Zamora, and Gunduz on the publication of “Weight and survival after deep brain stimulation for Parkinson’s disease,” which appears in the August 17th issue of Parkinsonism and Related Disorders. Abstract Background Weight loss in Parkinson’s disease (PD) is common and associated with increased mortality. The…

Rate of hallucinations and hospitalizations in PD: which medication is the best?

Hallucinations and delusions from psychosis are not uncommon for people living with Parkinson’s disease (PD). According to the Parkinson’s Foundation, between 20-40% of people living with PD report hallucinations with the likelihood increasing as someone living with PD ages. The only FDA-approved medication for hallucinations in Parkinson disease is pimavanserin (commonly sold…

Muhammad Ali and Young-Onset Idiopathic Parkinson Disease—The Missing Evidence

Congratulations to Dr. Okun on the publication of “Muhammad Ali and Young-Onset Idiopathic Parkinson Disease—The Missing Evidence.”  This paper was published in the October 24th edition of JAMA Neurology. Following Muhammad Ali’s death, there has been persistent dialogue about the degree to which Parkinson disease vs repetitive boxing-related head trauma…

The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism

Congratulations Dr Nikolaus McFarland, on the publication of “The TOPAZ study: a home-based trial of zoledronic acid to prevent fractures in neurodegenerative parkinsonism,” in the March 1 issue of Nature Portfolio Journals.   Abstract The Trial of Parkinson’s And Zoledronic acid (TOPAZ, https://clinicaltrials.gov/ct2/show/NCT03924414) is a unique collaboration between experts…

A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study

Congratulations Dr. Nikolaus McFarland on the publication of “A New MRI Measure to Early Differentiate Progressive Supranuclear Palsy From De Novo Parkinson’s Disease in Clinical Practice: An International Study.”  This paper was published in the November 2020 issue of Movement Disorders. ABSTRACT Background Enlargement of the third ventricle has been…